Physician profile
Chelsie A Morrison
NPI 1710111935
$442.85
in general payments reported to CMS, 2019-2025
12 companies · $85.99 in 2025
The $85.99 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.16 · 2020: $11.27 · 2021: $114 · 2022: $109 · 2023: $44.53 · 2024: $53.23 · 2025: $85.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $183.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $128.95 | 2021-2025 | |
| Novo Nordisk INC | $90.97 | 2021-2024 | Ozempic, Rybelsus |
| Lilly USA, LLC | $56.53 | 2020-2025 | Zepbound, Mounjaro |
| Phathom Pharmaceuticals, INC. | $30.96 | 2024-2025 | Voquezna |
| Amarin Pharma, INC. | $25.16 | 2019 | |
| Abbott Laboratories | $23.72 | 2022 | |
| Teleflex LLC | $18.14 | 2024 | Urolift |
| Impel Pharmaceuticals INC. | $17.67 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.86 | 2021 | |
| Pfizer INC. | $13.49 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.02 | 2021 | |
| Merck Sharp & Dohme LLC | $11.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chelsie Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.